Latest Breaking News On - Belcher pharmaceuticals - Page 1 : comparemela.com

Southeast Litigation Update: February 2024 - Patent

This is part of a series of articles discussing recent orders of interest issued in IP cases by the United States District Courts in the Southeast.

Pfizer Alleges Inconsistencies in Moderna's Statements to FDA and PTAB

In a recent brief to the Patent Trial and Appeal Board, Pfizer told PTAB judges that Moderna’s dismissal of prior art listed in Pfizer’s August 2023 petition for inter partes review of Moderna’s patent on mRNA vaccine technology is inconsistent with its declarations to the FDA.

Hyperkalemia Treatment Market Share 2023 | Vifor Pharma, Astrazeneca, Sanofi, CMP Pharma

Vitiligo Treatment Market Update 2023: Expected to Surpass USD 625.8 Million Revenue by 2031, Report

The vitiligo treatment market size was valued at $410.54 million in 2021, and is estimated to reach $625.8 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.Vitiligo Treatment Market in Short:CAGR: 4.3%Current Market Size: USD 410.54 MillionFastest Growing Region: APACLargest Market: North AmericaProjecti.

Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study

Time to maximum blood concentration for Anaphylm was 10 minutes with a range of 5 to 20 minutesEarly drug exposure at 10 minutes for Anaphylm was similar to Auvi-Q® auto-injector 0.3mg and over. | May 31, 2023